PharVision Advisers’s SunCoke Energy SXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$121K Buy
+15,048
New +$116K 2.28% 8
2025
Q3
– Sell
-12,762
Closed -$110K – 792
2025
Q2
$110K Sell
12,762
-30,018
-70% -$260K 0.16% 248
2025
Q1
$394K Sell
42,780
-6,718
-14% -$64.5K 0.55% 35
2024
Q4
$530K Buy
+49,498
New +$530K 0.45% 36

Other funds holding SXC

PharVision Advisers's SXC Position: Q2 2026 in Review

PharVision Advisers opened a new position in SunCoke Energy (SXC) in Q2 2026: 15,048 shares worth $121K. The stake represents 2.28% of the portfolio and ranks #8 among its holdings. This is a return to the name: PharVision Advisers previously reported a position in SXC as recently as Q2 2025.

PharVision Advisers first reported a position in SXC in Q4 2024 and has held it in 4 quarters since. The position peaked at $530K in Q4 2024. 237 funds tracked by Wall St. Rank hold SXC as of Q2 2026.

  • PharVision Advisers held 15,048 shares of SunCoke Energy worth $121K as of Q2 2026.
  • SunCoke Energy was a new PharVision Advisers position in Q2 2026.
  • SunCoke Energy made up 2.28% of PharVision Advisers's portfolio in Q2 2026, its #8 holding.
  • PharVision Advisers first reported a position in SunCoke Energy in Q4 2024 and has held it in 4 quarters since.
  • PharVision Advisers's SunCoke Energy position peaked at $530K in Q4 2024.
  • 237 funds tracked by Wall St. Rank held SunCoke Energy as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.